Eagle's Eye View: Your Weekly CV Update From ACC.org

Short-term DAPT, PCI & High Bleeding Risk; Dapagliflozin & Heart Failure; Non-Pharmacologic Treatment of HF

6 snips
Mar 12, 2025
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Short-Term DAPT Works Equally in Men and Women

  • Short-term dual antiplatelet therapy (DAPT) shows similar effectiveness and bleeding risks in men and women after PCI.
  • Women with obstructive coronary disease benefit from shortened DAPT durations just as men do.
INSIGHT

Dapagliflozin Benefits Severe Heart Failure

  • Dapagliflozin reduces cardiovascular death and heart failure hospitalization across all severity levels and ejection fractions.
  • Even patients with advanced heart failure benefit from this SGLT2 inhibitor.
ADVICE

Non-Pharmacologic Heart Failure Treatments

  • Use diet modifications like DASH or Mediterranean diets to manage heart failure, focusing on sodium restriction.
  • Employ exercise training and address sleep disorders to improve heart failure morbidity and function.
Get the Snipd Podcast app to discover more snips from this episode
Get the app